This post was contributed by a community member. The views expressed here are the author's own.

Health & Fitness

Surgical Delivery of Clot-Busting Drug Shows Promise

Stroke patients who had surgery to deliver the clot-busting drug tPA directly into the brain experienced better and quicker recovery than those who received standard treatment.

Stroke patients who had surgery to deliver the clot-busting drug tPA directly into the brain experienced better and quicker recovery than those who received standard treatment, according to researchers at the Johns Hopkins School of Medicine.

There are two types of stroke: hemorrhagic and ischemic. Though their symptoms appear similar, they are very different health emergencies that require different treatment.

Ischemic stroke happens when an artery in the brain is blocked. This causes brain tissue to die in the area served by the blocked vessel. Doctors can unblock the vessel with clot-busting drugs and mechanical devices.
Hemorrhagic stroke occurs when a weakened blood vessel ruptures and bleeds into the brain. While it is less common than ischemic stroke, it remains a major public health problem.

Find out what's happening in Plainviewwith free, real-time updates from Patch.

Doctors haven’t used clot-busting drugs to treat hemorrhagic stroke because they believed it could cause more bleeding. The only options were to monitor the patient or to remove the clot and alleviate intracranial pressure via cranial surgery, which could add risk.

However, Johns Hopkins researchers reported that tPA improved hemorrhagic stroke outcomes in a multicentered study of 96 patients. It appears that tPA not only didn’t cause more bleeding, but also dissolved the clots medically–without surgical removal. The results showed improved early and long-term recovery.

Find out what's happening in Plainviewwith free, real-time updates from Patch.

More research is necessary to fully understand the effects of these powerful drugs. But this preliminary work represents real progress in developing safer treatment and management of hemorrhagic stroke patients.

This post was written by David Langer, MD, Director of Cerebrovascular Research
at North Shore University Hospital and Associate Professor of Neurosurgery
at Hofstra North Shore-LIJ School of Medicine.

Contents of the health blog are the property of North Shore-LIJ Health System and are provided as a health resource for consumers, health care professionals and members of the media. The medical content on the North Shore-LIJ Health Blog is for informational purposes only and should not be considered a substitute for consultation with your physician regarding diagnosis, treatment or any other form of specific medical advice.   These materials may be reprinted for noncommercial personal use only. "North Shore-LIJ Health System," "North Shore-LIJ," "northshorelij.com," "VivoHealth," their related entities and logos are trademarks of the North Shore-LIJ Health System. Copyright © 2011 North Shore-LIJ Health System.  All rights reserved.

We’ve removed the ability to reply as we work to make improvements. Learn more here

The views expressed in this post are the author's own. Want to post on Patch?